Author

N. Bendriss-Vermare

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:cell type annotation· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

C. Caux· 4 shared J. Valladeau-Guilemond· 3 shared A. Sanlaville· 2 shared A. Voissiere· 2 shared D. Poujol· 2 shared J. Mussard· 2 shared M. Hubert· 2 shared M.-C. Michallet· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

C. Caux

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

CD4 T cells and neutrophils contribute to epithelial-mesenchymal transition in breast cancer

A. Sanlaville, A. Voissiere, D. Poujol, M. Hubert, S. Andre, C. Perret, J.-P. Foy, N. Goutagny, M. Malfroy, I. Durand, M. Chalons, J. Valladeau-Guilemond, P. Saintigny, A. Puisieux, C. Caux, , N. Bendriss-Vermare

The paper shows CD4 T cells and neutrophils promote EMT in breast cancer by analyzing murine tumor models and human cohorts.

bioRxiv · Feb 15, 2023 · PreprintCancer Biology

A Unique Polyfunctional IL-33-responsive ST2⁺ NK cell State Potentiates Antitumor Immunity and Response to Immunotherapy

A. Eberhardt, E. Blanc, V. Picant, A. Voissiere, L. Revol-Bauz, T. Casini, V. Alcazer, D. Poujol, L. Tonon, R. Schneider, E. Picard, Y. Rocca, M. Ardin, F. Onodi, C. Degletagne, , N. Bendriss-Vermare

The paper identifies a unique ST2+ NK cell state that enhances antitumor immunity and response to immunotherapy through IL-33 and IL-12 signaling.

bioRxiv · Feb 14, 2023 · PreprintCancer Biology

cDC1 and interferons promote spontaneous CD4+ and CD8+ T cell protective responses to breast cancer

R. Mattiuz, C. Brousse, M. Ambrosini, J.-C. Cancel, G. Bessou, J. Mussard, A. Sanlaville, C. Caux, N. Bendriss-Vermare, J. Valladeau-Guilemond, M. Dalod, K. Crozat

This study shows that cDC1 and interferons are critical for CD4+ and CD8+ T cell responses against breast cancer, promoting infiltration and effector functions, and improving patient prognosis.

bioRxiv · Dec 23, 2020Immunology

Efficient and specific Ly6G+ cell depletion: A change in the current practices toward more relevant functional analyses of neutrophils

J. Faget, G. Boivin, P.-B. Ancey, A. Gkasti, J. Mussard, C. Engblom, C. Pfirschke, J. Vazquez, N. Bendriss-Vermare, C. Caux, M.-C. Vozenin, M. J. Pittet, M. Gunzer, E. Meylan

The paper compares anti-Gr1 and anti-Ly6G antibodies for neutrophil depletion, showing anti-Ly6G's inefficacy in C57BL/6 mice but its potential for specific depletion when combined with a secondary antibody.

bioRxiv · Dec 18, 2018 · PreprintImmunology